(Q40580039)

21 September 2017

MEK inhibition impairs influenza B virus propagation without emergence of resistant variants (English)

1 reference

21 September 2017

influenza B virus

1 reference

1

1 reference

21 September 2017

7

Stephan Pleschka

1 reference

21 September 2017

Thorsten Wolff

2

1 reference

21 September 2017

Christina Ehrhardt

3

1 reference

21 September 2017

Walter Jürgen Wurzer

4

1 reference

21 September 2017

Jens Reinhardt

5

1 reference

21 September 2017

Oliver Planz

6

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

21 September 2017

1 reference

21 September 2017

561

1 reference

21 September 2017

37-43

1 reference

21 September 2017

1-3

1 reference

Inhibition of CD3/CD28-mediated activation of the MEK/ERK signaling pathway represses replication of X4 but not R5 human immunodeficiency virus type 1 in peripheral blood CD4(+) T lymphocytes

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

Activation of ERK2 by respiratory syncytial virus in A549 cells is linked to the production of interleukin 8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

JNK2 and IKKbeta are required for activating the innate response to viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

p38 mitogen-activated protein kinase and c-jun-NH2-terminal kinase regulate RANTES production by influenza virus-infected human bronchial epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

The vesicular stomatitis virus matrix protein inhibits glycoprotein 130-dependent STAT activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

Amantadine-resistance as a Genetic Marker for Influenza Viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

A fatal relationship--influenza virus interactions with the host cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

Amantadine inhibits RANTES production by influenzavirus-infected human bronchial epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

The molecular basis of the specific anti-influenza action of amantadine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

Molecular basis of resistance of influenza A viruses to amantadine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

Failure to obtain drug-resistant variants of influenza virus after treatment with inhibiting doses of 3-deazaadenosine and H 7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

Host-range mutant of fowl plague virus (FPV): Comparison of the genome and virus proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

Nuclear trafficking of influenza virus ribonuleoproteins in heterokaryons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900108-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-5793(04)00108-5

1 reference

21 September 2017

1 reference